Chunghwa Chemical Synthesis & Biotech Co., Ltd.

NT$30.95As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1762Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 3.04%
Div yield 0.62%
ROE (1.60%)
Biotechnology
Beta (5Y) 0.52
PE TTM —
TSR TTM 19.96%
Mkt cap NT$2.381B
ROIC (3.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$31
0.09%
(52.94%)
Hold 7|7|7|8|6
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.81
0.83
0.81
0.86
36.55%
25.71%
16.34%
14.94%
RevenueNT$M
186.3
189.8
200.2
198.3
(0.57%)
3.35%
8.70%
5.69%
Peers (US$71.90M)
Cap (US$)
PE
71.86M
—
Capital
TTM
5Y
10Y
Leveragex
4.139
0.017
0.016
EBIT/Intx
0.439
1.649
1.571
Own earn%
28.26
43.43
52.27
Sh yield%
34.07
60.76
59.08
Owners
Insiders/Inst%
4.27
72.35
Short interest%
0.97
SBC / revenue%
0.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
14–19
$1 testx
—
Incr. ROIC%
14